Authors: Lin, YM Raffen, R Zhou, YS Cassidy, CS Flavin, MT Stevens, FJ

Citation: Ym. Lin et al., Amyloid fibril formation in microwell plates for screening of inhibitors, AMYLOID, 8(3), 2001, pp. 182-193

Authors: Davis, DP Gallo, G Vogen, SM Dul, JL Sciarretta, KL Kumar, A Raffen, R Stevens, FJ Argon, Y

Citation: Dp. Davis et al., Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain, J MOL BIOL, 313(5), 2001, pp. 1021-1034

Authors: Kim, YS Cape, SP Chi, E Raffen, R Wilkins-Stevens, P Stevens, FJ Manning, MC Randolph, TW Solomon, A Carpenter, JF

Citation: Ys. Kim et al., Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains, J BIOL CHEM, 276(2), 2001, pp. 1626-1633

Authors: Davis, DP Raffen, R Dul, JL Vogen, SM Williamson, EK Stevens, FJ Argon, Y

Citation: Dp. Davis et al., Inhibition of amyloid fiber assembly by both BiP and its target peptide, IMMUNITY, 13(4), 2000, pp. 433-442

Authors: Raffen, R Dieckman, LJ Szpunar, M Wunschl, C Pokkuluri, PR Dave, P Stevens, PW Cai, XY Schiffer, M Stevens, FJ

Citation: R. Raffen et al., Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains, PROTEIN SCI, 8(3), 1999, pp. 509-517

Authors: Raffen, R Stevens, FJ

Citation: R. Raffen et Fj. Stevens, Small zone, high-speed gel filtration chromatography to detect protein aggregation associated with light chain pathologies, METH ENZYM, 309, 1999, pp. 318-332